+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Alpha Mannosidosis Drug"

Alpha Mannosidosis Global Market Report 2024 - Product Thumbnail Image

Alpha Mannosidosis Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Alpha Mannosidosis: Global Strategic Business Report - Product Thumbnail Image

Alpha Mannosidosis: Global Strategic Business Report

  • Report
  • April 2024
  • 194 Pages
  • Global
From
Alpha-Mannosidosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Alpha-Mannosidosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Alpha Mannosidosis is a rare genetic disorder that affects the body's ability to break down certain sugars. Endocrine and Metabolic Disorders Drugs are used to treat this disorder. These drugs are designed to reduce the amount of sugar in the body, as well as to help the body break down the sugar more efficiently. Common drugs used to treat Alpha Mannosidosis include enzyme replacement therapy, gene therapy, and other medications. The Alpha Mannosidosis Drug market is a small but growing market, with a focus on providing treatments for this rare disorder. Companies in this market are focused on developing treatments that are safe and effective, as well as providing support for patients and their families. Some of the companies in this market include Genzyme, Shire, and Sanofi. Show Less Read more